<DOC>
	<DOCNO>NCT00761332</DOCNO>
	<brief_summary>The purpose study compare effectiveness teriparatide versus therapy decrease bone loss prevent new worsen back pain patient osteoporosis see clinical practice .</brief_summary>
	<brief_title>Back Pain Patients With Severe Osteoporosis</brief_title>
	<detailed_description>Study B3D-CR-B013 prospective observational study compare change back pain among patient treat teriparatide versus treat antiresorptives ( raloxifene , daily weekly bisphosphonates ) .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Men postmenopausal woman previous vertebral osteoporotic fracture sustain least 6 week prior join study . Patients free severe chronically disable condition osteoporosis . Patients currently receive previously receive teriparatide . Patients agree participate , return followup visit , sign inform consent participate study . Patients , opinion prescribe physician , eligible receive intend treatment comply recommendation state relevant product information . Are investigator site personnel directly affiliate study and/or immediate family . Immediate family define spouse , parent , child , sibling , whether biological legally adopt . Are Lilly employee ( , employee , temporary contract worker , designees responsible conduct study ) . Immediate family Lilly employee may participate Lillysponsored clinical trial , permit participate Lilly facility . Patients contraindication accord relevant product information country treat . Patients simultaneously participate different study include treatment intervention and/or investigational drug .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>